MedPath
HSA Approval

DAVMORID FILM COATED TABLET

SIN16960P

DAVMORID FILM COATED TABLET

DAVMORID FILM COATED TABLET

February 20, 2024

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantYUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

C05CA53

diosmin, combinations

Manufacturer Information

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Y.S.P. Industries (M) Sdn. Bhd.

Active Ingredients

Diosmin

450mg

Diosmin

Hesperidin

50mg

Hesperidin

Documents

Patient Information Leaflets

Davmorid Film Coated Tablet PIL.pdf

Approved: February 20, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DAVMORID FILM COATED TABLET - HSA Approval | MedPath